Abstract
Checkpoint inhibitor antibody type influences the development of cutaneous immune-related adverse events: A multi-institutional study
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
https://doi.org/10.1016/j.jaad.2023.09.031
Publication Date: Sep 18, 2023 |
Checkpoint inhibitor antibody type influences the development of cutaneous immune-related adverse events: A multi-institutional study
Join us for a 30 min session where you can share your feedback and ask us any queries you have